The exact survival time for patients with mid- to late-stage esophageal cancer varies from person to person.
Survival time after treatment may vary depending on the individual’s physical condition, disease, and treatment method. In addition, the degree of psychological impact of the disease on the patient also has a major impact on the healing process.
If the patient is in the prime of life and is in the middle stage of esophageal cancer, the prognosis is generally better with surgery and radiotherapy, and the 5-year survival rate is higher.
Older patients will be in a reduced physical condition themselves and may not be suitable for surgical treatment. The treatment by chemotherapy and radiotherapy alone can delay the disease, but the patient’s survival time will mostly be affected. The patient’s survival time will be affected by the chemotherapy and radiotherapy side effects, if not tolerated.
Patients are in a good psychological state and actively cooperate with their doctors for treatment review. It helps to improve survival time. If the patient has lost confidence, the disease tends to progress more rapidly and survival time is reduced.
In summary, patients with mid-stage esophageal cancer who are in good physical and mental health generally have a longer survival time after treatment, on average about three years or even longer. Patients with advanced esophageal cancer who have poor psychological profile or deviant physical condition may survive between six months and a year.